Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Liaoning Chengda Co's share price for the quarter that ended in Mar. 2026 was ¥11.24. Liaoning Chengda Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,522 Mil. Therefore, Liaoning Chengda Co's market cap for the quarter that ended in Mar. 2026 was ¥17,111 Mil.
Liaoning Chengda Co's quarterly market cap
declined
from Sep. 2025 (¥18,800 Mil) to Dec. 2025 (¥17,102 Mil) but then
increased
from Dec. 2025 (¥17,102 Mil) to Mar. 2026 (¥17,111 Mil).
Liaoning Chengda Co's annual market cap
declined
from Dec. 2023 (¥18,020 Mil) to Dec. 2024 (¥15,832 Mil) but then
increased
from Dec. 2024 (¥15,832 Mil) to Dec. 2025 (¥17,102 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Liaoning Chengda Co's Enterprise Value for Today is ¥26,302 Mil.
Liaoning Chengda Co (SHSE:600739) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Liaoning Chengda Co Market Cap Related Terms
Liaoning Chengda Co Market Cap Historical Data
* Premium members only.
The historical data trend for Liaoning Chengda Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600739 vs MCK, CAH, COR: Market Cap Comparison
For the Medical Distribution subindustry, Liaoning Chengda Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liaoning Chengda Co Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Liaoning Chengda Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Liaoning Chengda Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Liaoning Chengda Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Co (SHSE:600739) has a Market Cap of ¥16,730 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Liaoning Chengda Co and its competitors. According to the industry distribution chart, Liaoning Chengda Co ranks #18 out of 120 companies in the Medical Distribution industry, placing it in the top 15%.
Is Liaoning Chengda Co's Market Cap too high?
Liaoning Chengda Co's current Market Cap is ¥16,730 Mil. Based on the distribution chart, Liaoning Chengda Co ranks #18 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Liaoning Chengda Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Co's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Liaoning Chengda Co ranks #18 out of 120 companies for Market Cap. This places Liaoning Chengda Co in the top 15% of its industry — outperforming the majority of peers. The industry median Market Cap is 147.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 147.52, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Liaoning Chengda Co and its competitors. For the Medical Distribution industry, the median Market Cap is 147.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liaoning Chengda Co's current Market Cap is ¥16,730 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Co (SHSE:600739) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥9.70, compared to a current price of ¥10.99 — trading 13.3% above its estimated fair value. The current Market Cap is ¥16,730 Mil. Liaoning Chengda Co's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Liaoning Chengda Co (SHSE:600739), the current Market Cap is ¥16,730 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liaoning Chengda Co (SHSE:600739) Overvalued in 2026?
Based on GuruFocus' analysis, Liaoning Chengda Co stock appears to be overvalued.
The current stock price of ¥10.99 is trading 13.3% above its estimated GF Value™ of ¥9.70.
GuruFocus considers Liaoning Chengda Co to be Modestly Overvalued.
Key valuation signals for SHSE:600739:
Market Cap: ¥16,730 Mil
GF Value™: ¥9.70 vs. price of ¥10.99 (13.3% above fair value)
No single metric tells the full story. See the SHSE:600739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liaoning Chengda Co Ltd is engaged in the business of pharmaceutical and medical, domestic and foreign trade, financial investment, and energy development. The trading division is engaged in the trading of textiles and clothing, steel, wood, and aquatic products. The company is also involved in securities, insurance, and fund business through its financial investment division.
54GF Score
Get the complete analysis for SHSE:600739
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600739 has been successfully added to your 
